chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I was cleaning my oven on March 19, 2023, in the morning, around 2:30PM I got up in from my chair and had the worst pain in my back. I made and appointment with my doctor but could not get in to see her until Tuesday March 21, 2023. She ran bloodwork that did show that I had an UTI infection but did prescribe medication. I took the medication, but it did not help at all. By Thursday, March 23, 2023, I went to the emergency to find out if I had a kidney stones. They did an ultrasound and found that I did not have a kidney stone or kidney obstruction. He felt I may have a muscle strain and sent me home. I had to go through the weekend in pain. On Monday I went to my physical therapy appointment. I described what my pain was, they told me it was my SI joint. They were able to put my joint back in place, I woke up on Tuesday able to walk like a new person.
This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (He received his 2nd dose of Moderna Covid-19 vaccine, on the 14th day) in a 29-year-old male patient who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis. No Medical History information was reported. On 17-Jun-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 01-Jul-2022, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 01-Jul-2022, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (He received his 2nd dose of Moderna Covid-19 vaccine, on the 14th day). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (He received his 2nd dose of Moderna Covid-19 vaccine, on the 14th day) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. Unknown if AE cause patient to seek medical care (office visit, Urgent care, ER, hospitalized). Unknown if the patient experienced a similar event in the past. Unknown if symptoms improved or worsened. Treatment information was not provided.
Patient was administered a third moderna covid vaccine dates given were 2/11/21, 3/11/21, and 3/21/21
Both arms developed itching and a bright red maculopapular lacy rash from shoulder to hands. No hives no respiratory or systemic sx.
"RASH ON LEGS, STOMACH, AND CHEEKS" PER MOTHER'S STATEMENT.
Information has been received from a RN concerning an 8 y/o white female child with no past medical history and no known drug allergies who in September 1995 was vaccinated with a dose of varicella virus vaccine live. There was no illness at the time of vaccination. It is unknown if there were adverse events following prior vaccinations of the patient or her siblings. On 16Apr2003 the pt developed multiple macules and pustales and some scabs on her trunk, face, and extremities. The pt was treated with acyclovir (ZOVIRAX) x 5 days. The reporter indicated that the pt recovered. No diagnostic tests or laboratory data were reported. No further information is expected.
Pt received vaccination at 1728, experienced dizziness at 1732. Patient positioned recumbent, given water and apple juice and observed.
A 69-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot# EP7533), via unspecified route of administration in left arm on 6Apr2021 at 2:40PM at single dose for COVID-19 immunization. The patient was not administered with prior vaccine within four weeks. Patient had a history of ongoing high blood pressure. The patient's concomitant medication included ongoing Amlodipine Besylate at 5mg one tablet one time a day for high blood pressure and ongoing. On 14Apr2021, patient experienced her left eye got blurry. She doesn't know if her eye getting blurry is coming from the Covid-19 vaccine. She hasn't taken the second Covid-19 vaccine yet. She reports her eye might be blurry because of the Covid-19 vaccine. She reports the left eye blurriness started about 4 or 5 days ago on 14Apr2021. Her eye was getting blurry a little bit then it seemed to get worse, now it's staying about the same. It seems like there is something in her eye, just her left eye. When she tries to read, the letters are blurry but if she puts what she's reading up close to her face she can make the letters out. She reports her husband got his Covid 19 vaccine first and she was skeptical about getting the vaccine for herself. On 25Nov2020, when she went to the doctor on for a regular checkup, he changed one of her medications and she didn't notice the change. She doesn't know if she needs glasses. She doesn't wear glasses not even to read. She tried reading glasses but they gave her a headache. She has made an appointment to see an eye doctor. She reports it seems like there is something in her left eye. She might have cataracts. She has an eye appointment in about 3 weeks on 04May2021 or 05May2021. She can see fine out of her right eye and she can see out of her left eye she just has to put what she's reading close to her left eye to see it. No emergency Room/ Physician Office due to AE. Outcome of the events was not resolved.
Patient came back to the vaccination site and reported/showed her having a localized rash on the arm one hour after getting vaccinated.  After asking the patient if she's experiencing any other symptoms, it was determined that this is not a severe allergic reaction needing a more intensive intervention. No benadryl was given or was 911 called. Patient was followed up with around 12:45pm and the rash was nearly gone.  The patient was referred to see her physician to determine what she is allergic to. We recommend holding the second dose pending a physician evaluation.
pt recv vax 1NOV95 & devel an inj site rxn characterized by induration & erythema;pt also exp malaise & nausea;this is one of four patients from this site who exp above sx
patient received vaccine, was fine, about 4 minutes later she lost consciousness and fell out of her chair and began having a seizure.  at this point I rushed to her to turn her on her side and monitored pulse, breathing until she regained consciousness about 30 seconds later.
Taste of metal (metallic taste) in her mouth; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Taste of metal (metallic taste) in her mouth) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced DYSGEUSIA (Taste of metal (metallic taste) in her mouth). On 11-Jan-2021, DYSGEUSIA (Taste of metal (metallic taste) in her mouth) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Patient did not receive any treatment.  Company comment:Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
dry cough; bedridden; chills at night; headache; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (dry cough), BEDRIDDEN (bedridden), CHILLS (chills at night) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   In September 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In September 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2022, the patient experienced COUGH (dry cough), BEDRIDDEN (bedridden), CHILLS (chills at night) and HEADACHE (headache). At the time of the report, COUGH (dry cough), BEDRIDDEN (bedridden), CHILLS (chills at night) and HEADACHE (headache) outcome was unknown.            Concomitant products were not reported.  It was reported that patient had first doses of Moderna COVID-19 immunization in Sep-2021. Patient also mentioned that she probably had COVID.  Treatment medications were not reported.   Reporter did not allow further contact
Tiredness; Vaccination site pain/left arm soreness from covid vaccine; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tiredness) and VACCINATION SITE PAIN (Vaccination site pain/left arm soreness from covid vaccine) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product UPADACITINIB (RINVOQ) for Rheumatoid arthritis.    There was no reported medical history.    In 2021, the patient UPADACITINIB (RINVOQ) (Oral) dosage was changed to at an unspecified dose. On 30-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started UPADACITINIB (RINVOQ) (Oral) at an unspecified dose. In August 2021, the patient experienced FATIGUE (Tiredness) and VACCINATION SITE PAIN (Vaccination site pain/left arm soreness from covid vaccine). In 2021, FATIGUE (Tiredness) and VACCINATION SITE PAIN (Vaccination site pain/left arm soreness from covid vaccine) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No concomitant medication details were provided. No treatment medication details were provided.   The reporter's causality for the events of vaccination site pain and fatigue was not provided.  The patient had her Covid booster and was tired for a day or two and her left arm sore from the shot. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in
Muscle tightness in upper back (shoulders); soreness in upper back (shoulders); Headache; Mild fever ranging between 99.7 - 100.8 degreesFahrenheit; Lower back pain/muscle soreness; Lower back muscle soreness; Chills; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 12May2021 at 14:00 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not receive any medication within two weeks of vaccination. The patient previously received first dose BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 19Apr2021 at 14:00 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  On 12May2021, the patient experienced chills at around 16:00 lasting approx. 15 minutes, lower back pain/muscle soreness at 16:30, headache and mild fever ranging between 99.7 - 100.8 degrees Fahrenheit at 2100 and significant muscle tightness/soreness in upper back (shoulders) at 21:30. Headache lasted till 14May2021 and ultimately took naproxen which alleviated it and has not returned. All other symptoms were resolved by 13May2021. On 12May2021 patient underwent lab test which include body temperature and the result was ranging between 99.7 - 100.8 degrees Fahrenheit. Therapeutic measures were taken as a result of headache and included treatment with naproxen (MANUFACTURER UNKNOWN). No therapeutic measures were taken for other events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of chills was recovered at 16:15 on 12May2021, mild fever, muscle tightness/soreness in upper back (shoulders) and lower back pain/muscle soreness were recovered on 13May2021 and headache was recovered on 14May2021.   No follow-up attempts are needed. No further information is expected.
Brain fog; Severe body aches; Painful lymph nodes under left armpit; Low grade fever; Chills; Headaches; Extreme fatigue; Left arm pain at injection site; Swelling of lymph nodes under left armpit; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 08Apr2021 at 11:30 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history included obesity, high cholesterol and sulphonamide allergy. Concomitant medications included zafirlukast (MANUFACTURER UNKNOWN), ezetimibe (ZETIA), colecalciferol (VITAMIN D3), ascorbic acid; herbal nos; levoglutamide; lysine; magnesium; manganese; retinol; riboflavin; selenium; tocopherol; zinc (AIRBORNE) and ibuprofen (MANUFACTURER UNKNOWN) all for an unknown indication from an unknown date. The patient previously took codeine, quinolones and Zantac and experienced allergy to these medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 18Mar2021 at 11:30 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 22:00, the patient experienced low grade fever and chills, severe body aches, headaches, extreme fatigue, left arm pain at injection site, painful swelling of lymph nodes under left armpit and brain fog. The patient did not receive any treatment for the events. The symptoms were the worst between 10 and 48 hours post vaccine but were still present to a lesser extent as of 76 hours post vaccine. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the events low grade fever and chills, severe body aches, headaches, extreme fatigue, left arm pain at injection site, painful swelling of lymph nodes under left armpit and brain fog was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Having non stop low frequency tinnitus that I have not experienced before. Interrupt rest at night and distract work during work. Sometimes it goes extremely loud that really hard to handle. It becomes very sensitive responds to sounds.
Rec?d ModernaCovid vaccine. Day2-3 had headache,sore arm, fatigue and an unwell feeling.  Day 9 a red rash 3? in diameter formed at injection site. Day 10 had dizziness.  Day 11 a swollen lymph node size of a small egg under right arm.  Day 12 &13 painful joints.
This case was reported by a other health professional and described the occurrence of vaccination failure in a adult patient who received BEXSERO. On an unknown date, the patient received BEXSERO at an unknown dose. On an unknown date, an unknown time after receiving BEXSERO, the patient experienced vaccination failure (serious criteria GSK medically significant) and meningococcal infection (serious criteria death and GSK medically significant). On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the meningococcal infection was fatal. The reported cause of death was meningococcal infection. It was unknown if the reporter considered the vaccination failure and meningococcal infection to be related to BEXSERO. Additional details were provided as follows: The age at vaccination was not reported. The patient asked for a kit to test the clinical mening isolate if the strain was covered by the vaccine. The patient died on an unknown date. It was unknown if the autopsy was performed. This case was considered as suspected vaccination failure as the details regarding vaccination schedule, time to onset for the event and lab test confirmation was unknown.
sore arm at site of injection; brief headache; This is a spontaneous report from a contactable pharmacist. A 25-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via intramuscular route of administration in the right arm on 20Mar2021 at 10:00 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any known allergies. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had not been tested for COVID-19 since having the vaccine. On 20Mar2021, the patient experienced sore arm at site of injection and brief headache. The date of awareness of this event was reported as 21Mar2021. The patient did not receive any treatment for events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of sore arm at site of injection and brief headache was unknown.   Information about lot number cannot be obtained. No further information is expected.
G45.9 TRANSIENT CEREBRAL ISCHEMIA 4/9/2023 ACUTE CHOLECYSTITIS G45.9 TRANSIENT CEREBRAL ISCHEMIA 4/9/2023 ACALCULOUS CHOLECYSTITIS
Swollen arm; Felt like I had a flu; Felt extreme thirst; Painful arm; dizziness; Fever; Nausea; Headache; Sore arm, Body Ache; Chills; Tired; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Painful arm), DIZZINESS (dizziness), INFLUENZA (Felt like I had a flu), THIRST (Felt extreme thirst) and VACCINATION SITE SWELLING (Swollen arm) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023MLDA and 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Thyroid disorder. Concurrent medical conditions included Latex allergy, Adhesive tape allergy, Type 2 diabetes mellitus and Thyroidectomy. Concomitant products included PLANTAGO OVATA FIBRE (FIBER SUPPLEMENT) for Supplementation therapy, LEVOTHYROXINE for Thyroidectomy, METFORMIN for Type 2 diabetes mellitus, VITAMIN B COMPLEX and VITAMIN C [ASCORBIC ACID] for Vitamin supplementation.   On 25-Jan-2021 at 9:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021 at 10:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Mar-2021, the patient experienced PAIN IN EXTREMITY (Painful arm), DIZZINESS (dizziness), THIRST (Felt extreme thirst), PYREXIA (Fever), NAUSEA (Nausea), HEADACHE (Headache), MYALGIA (Sore arm, Body Ache), CHILLS (Chills) and FATIGUE (Tired). On 20-Mar-2021, the patient experienced INFLUENZA (Felt like I had a flu). On 20-Mar-2021 at 8:00 AM, the patient experienced VACCINATION SITE SWELLING (Swollen arm). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. On 22-Mar-2021, VACCINATION SITE SWELLING (Swollen arm) had resolved. At the time of the report, PAIN IN EXTREMITY (Painful arm), DIZZINESS (dizziness), INFLUENZA (Felt like I had a flu), THIRST (Felt extreme thirst), PYREXIA (Fever), NAUSEA (Nausea), HEADACHE (Headache), MYALGIA (Sore arm, Body Ache), CHILLS (Chills) and FATIGUE (Tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Feb-2021, SARS-CoV-2 test: positive (Positive) Positive.         Action taken with mRNA-1273 in response to the event was Not Applicable   Most recent FOLLOW-UP information incorporated above includes: On 16-May-2021: Follow up information was received from the initial reporter: Patient's race, height and weight were added. Concomitant medications and event influenza  were added.
mild side effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (mild side effects) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced VACCINATION COMPLICATION (mild side effects). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (mild side effects) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported.
Wasnt told to wait immediately after vacine.  Felt ok for a minute or so, got onto the elevator started to feel dizzy and blacked out and face planted into the tile floor out of the elevator. They checked my blood pressure immediately after and took me up to my general doctor for observation and took my blood pressure few more times after.  Broke my 2 front teeth and will be needing dental cosmetic work done.
Patient was given vaccine outside of the 6 hour injection window.  Vaccine was in syringe for approximately 60 hours at room temperature.